Longevity Clinic Market Report 2026

The longevity clinic market size has grown rapidly in recent years. It will grow from $5.35 billion in 2025 to $6.02 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing demand for preventive healthcare, rising awareness of anti-aging therapies, growing adoption of personalized wellness programs, increasing focus on healthy lifespan extension, and rising interest in regenerative medicine services.

The longevity clinic market size is expected to see rapid growth in the next few years. It will grow to $9.55 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to rising consumer interest in longevity services, growing investment in regenerative medicine, rising adoption of digital wellness platforms, growing focus on personalized anti-aging therapies, and increasing preference for preventive care models. Major trends in the forecast period include advancement in biomarker-based diagnostics, advancement in regenerative medicine therapies, innovation in personalized longevity programs, innovation in age-reversal treatment models, and innovation in cellular rejuvenation therapies.

The increasing demand for preventive and personalized healthcare services is expected to propel the growth of the longevity clinic market in the coming years. Preventive and personalized healthcare refers to proactive medical approaches that identify individual health risks early, enable timely intervention, and deliver care plans tailored to a person’s genetic, metabolic, and lifestyle profile. This growing demand is driven by rising awareness of healthy aging, increasing life expectancy, and greater recognition that early management of chronic disease risk factors can significantly improve long-term health outcomes. Longevity clinics support this shift by offering comprehensive individualized assessments, advanced diagnostic testing, and customized interventions designed to optimize healthspan and delay the onset of age-related conditions. For instance, in July 2025, according to survey findings published by the National University of Singapore’s Academy for Healthy Longevity, approximately 58% of respondents expressed interest in attending healthy longevity or preventive medicine clinics that provide personalized health assessments. The survey also indicated a steady rise in public interest, increasing from around 40% in 2021 to nearly 58% in 2025, representing growth of more than 40% over four years. Therefore, the increasing demand for preventive and personalized healthcare services is driving the growth of the longevity clinic market.

Major companies operating in the longevity clinic market are increasingly focusing on establishing regulated healthy longevity medicine centres that integrate AI-enabled personalised longevity assessments to expand preventive care, optimise healthspan, and support age-targeted interventions. AI-enabled personalised longevity assessments use advanced analytics to combine genetic information, lifestyle factors, and biomarker data, generating customised prevention and wellness plans that help clinicians stratify patient risk, prioritise early interventions, and tailor care pathways to individual needs. For instance, in November 2024, the Department of Health - Abu Dhabi, a United Arab Emirates-based government health authority, launched the Institute for Healthier Living Abu Dhabi, the region’s first licensed Healthy Longevity Medicine Centre. The centre is designed to deliver comprehensive longevity-focused care by integrating personalised diagnostics, lifestyle optimisation programmes, and precision therapeutic planning. It also incorporates collaborative multi-specialty care models and AI-driven risk stratification systems, aimed at strengthening preventive care delivery and improving long-term patient outcomes.

In July 2025, Longevity Health Holdings, Inc., a US-based provider of regenerative bio-aesthetics, advanced diagnostics, nutrition products, and healthy aging solutions, acquired True Health Inc. for approximately $59 million. Through this acquisition, Longevity Health Holdings aims to expand its longevity clinic services and product portfolio by integrating True Health’s regulatory authorizations, operating licenses, and product development capabilities related to plasma-derived and therapeutic health technologies. This strategic move supports the delivery of more holistic, longevity-focused care by strengthening access to advanced diagnostics and therapeutic solutions. True Health Inc. is a US-based healthcare company specializing in plasma collection services and related health product authorizations essential for advanced diagnostic and therapeutic applications.

Major companies operating in the longevity clinic market are Six Senses, Healthspan Ltd., Fountain Life LLC, Cenegenics LLC, Parsley Health Inc., SHA Wellness Clinic S.L., The Golden Door, VIVAMAYR Medical Center, Longevity Medical Clinic USA, AEON Medical Pvt Ltd., Chenot, Defy Medical Inc., Nescens SA, AYUN Longevity Clinic, Paracelsus Clinic, Longevity Center Switzerland AG, Aluna Longevity Clinics, Vivant Medical Group, Optimum Performance Physical Therapy LLC, VidaVital Medical Clinics.

North America was the largest region in the longevity clinic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the longevity clinic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the longevity clinic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are influencing the longevity clinic market by increasing costs of imported diagnostic equipment, genetic testing tools, wearable sensors, and advanced laboratory instruments used in personalized health assessments. clinics in north america and europe are most affected due to reliance on imported medical technologies, while asia-pacific faces pricing pressure on advanced diagnostics adoption. these tariffs are raising setup and operational costs for new clinics. however, they are also encouraging local manufacturing of medical devices, regional diagnostic partnerships, and innovation in cost-efficient preventive healthcare solutions.

A longevity clinic is a specialized healthcare facility dedicated to extending healthy lifespan by emphasizing preventive, personalized, and proactive medical care. It typically provides comprehensive health assessments, advanced diagnostics such as biomarker and genetic testing, and tailored wellness or intervention programs designed to optimize physical, cognitive, and metabolic health. These clinics focus on early risk detection, lifestyle optimization, and targeted therapies to delay age-related decline, enhance resilience, and improve overall vitality and quality of life.

The key service types of longevity clinics include preventive care, diagnostic services, personalized medicine, wellness programs, anti-aging treatments, and other service categories. Preventive care focuses on early detection and lifestyle interventions to maintain health, reduce disease risk, and support longer, healthier lives. Therapy types include senolytic therapies, stem cell therapies, peptide therapies, IV infusions and nutrient therapy, and hyperbaric oxygen therapy. Technologies used include multi-omics (genomics and epigenetics), artificial intelligence and machine learning platforms, wearable sensors, and advanced imaging and diagnostic systems. Age groups served include adults, geriatric patients, and others, with end users including adults, elderly patients, hospitals, specialty clinics, and others.

The longevity clinic market consists of revenues earned by entities by providing services such as personalized health assessments, preventive wellness programs, anti-aging therapies, advanced diagnostic evaluations and hormonal and metabolic optimization treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.